1. Home
  2. RMNI vs XOMA Comparison

RMNI vs XOMA Comparison

Compare RMNI & XOMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rimini Street Inc. (DE)

RMNI

Rimini Street Inc. (DE)

HOLD

Current Price

$3.29

Market Cap

367.9M

ML Signal

HOLD

Logo XOMA Corporation

XOMA

XOMA Corporation

HOLD

Current Price

$25.00

Market Cap

308.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RMNI
XOMA
Founded
2005
1981
Country
United States
United States
Employees
N/A
13
Industry
Business Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
367.9M
308.6M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
RMNI
XOMA
Price
$3.29
$25.00
Analyst Decision
Buy
Strong Buy
Analyst Count
2
4
Target Price
$5.50
$63.25
AVG Volume (30 Days)
305.5K
707.5K
Earning Date
02-19-2026
03-16-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.47
0.82
Revenue
$425,959,000.00
$47,106,000.00
Revenue This Year
N/A
$77.29
Revenue Next Year
$4.11
$29.30
P/E Ratio
$6.81
$30.33
Revenue Growth
N/A
118.02
52 Week Low
$2.73
$18.35
52 Week High
$5.38
$39.92

Technical Indicators

Market Signals
Indicator
RMNI
XOMA
Relative Strength Index (RSI) 27.70 45.71
Support Level $3.17 $24.70
Resistance Level $3.54 $27.87
Average True Range (ATR) 0.13 1.51
MACD -0.04 0.02
Stochastic Oscillator 13.39 35.87

Price Performance

Historical Comparison
RMNI
XOMA

About RMNI Rimini Street Inc. (DE)

Rimini Street Inc and its subsidiaries are providers of end-to-end enterprise software support, products, and services. The Company offers a comprehensive family of unified solutions to run, manage, support, customize, configure, connect, protect, monitor, and optimize clients' enterprise applications, database, and technology software platforms. The Company derives revenues from clients by providing subscription support services for enterprise resource planning, customer relationship management, product lifecycle management database, and technology software systems. Geographically, the company generates the majority of its revenue from the United States of America and the International market.

About XOMA XOMA Corporation

XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes. Geographically, the company operates in Switzerland, United States, Asia Pacific, Europe and Others.

Share on Social Networks: